Call Text Chat Email Refer a Patient Join a Study

Search

MotherToBaby

Medications and More during pregnancy and breastfeeding

Formoterol (Foradil®)

Selected References:

  • Asghar FA, et al. 2024. LTRA use in pregnancy: a systematic review on their safety and association with congenital anomalies’. JRGM, 13(2):1-8.   
  • Committee on Drugs. American Academy of Pediatrics. 2001. The transfer of drugs and other chemicals into human milk. Pediatrics. 108:776-789. 
  • Cossette B, et al. 2014. Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy. Ann Allergy Asthma Immunol. 112(5):459-464. 
  • Eltonsy S, et al. 2011. Beta2-agonists use during pregnancy and the risk of congenital malformations. Birth Defects Research Clin Mol Teratol. 91(11):937-947. 
  • Gregersen TL, Ulrik CS. 2013. Safety of bronchodilators and corticosteroids for asthma during pregnancy: what we know and what we need to do better. J Asthma Allergy. 6:117-125. 
  • Lim A, et al. 2013. Asthma drugs in pregnancy and lactation. Aust Prescr. 36(5):150–153. 
  • Lim A, et al. 2011. Systematic review of the safety of regular preventive asthma medications during pregnancy. Ann Pharmacother. 45(7-8):931-945. 
  • Namazy J, Schatz M. 2018. Management of asthma during pregnancy: optimizing outcomes and minimizing risk. Semin Respir Crit Care Med. 39(01):29-35. 
  • National Asthma Education and Prevention Program. Working Group. 2004. Report on managing asthma during pregnancy: Recommendations for pharmacologic treatment. Update 2004. NIH publication NO.05-5236. Bethesda, MD: US Department of Health and Human Services; National Institutes of Health; National Heart, Lung and Blood Institute. 
  • Peterka M, ET AL. 2021. Anti-asthma Drugs Formoterol and Budesonide (Symbicort) Induce Orofacial Clefts, Gastroschisis and Heart Septum Defects in an In Vivo Model. In Vivo. 35(3):1451-1460.  
  • Tamasi L, et al. 2005. The management of bronchial asthma during pregnancy – Hungarian experiences. [Article in Hungarian] Orv Hetil. 146(45):2035-2039. 
  • Wilton LV, Shakir SA. 2002. A post-marketing surveillance study of formoterol (Foradil). Its use in general practice in England. Drug Saf. 25:213-223. 

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $1,200,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.